Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Dr Reddy's Laboratories Ltd
BSE:500124
Dr Reddy's Laboratories Ltd
BSE:500124
Price:
1 200.1
INR
-2.9%
Market Closed
Market Cap:
₹199.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
D
|
Dr Reddy's Laboratories Ltd
BSE:500124
|
IN |
|
Tiger Brands Ltd
OTC:TBLMF
|
ZA |
|
Telecom Italia SpA
F:TQIA
|
IT |
|
A
|
ASM International NV
XMUN:AVS
|
NL |
|
Ryanair Holdings PLC
F:RY4D
|
IE |
|
Winnebago Industries Inc
NYSE:WGO
|
US |
|
V
|
Vulcan Materials Co
LSE:0LRK
|
US |
|
Solo Brands Inc
OTC:SBDS
|
US |
|
S
|
Starflex PCL
SET:SFLEX
|
TH |
|
G
|
GlaxoSmithKline PLC
NYSE:GSK
|
UK |
|
A
|
American States Water Co
XMUN:FDK
|
US |
|
Gold Fields Ltd
OTC:GFIOF
|
ZA |
|
W
|
Wharf Holdings Ltd
OTC:WARFF
|
HK |
|
S
|
Schneider Electric SE
F:SND
|
FR |
|
H
|
Hiremii Ltd
ASX:HMI
|
AU |
|
H
|
HMS Hydraulic Machines & Systems Group PLC
MOEX:HMSG
|
RU |
|
F
|
Ford Motor Co
BMV:F
|
US |
|
C
|
Cameco Corp
DUS:CJ6
|
CA |
|
A
|
ASM International NV
OTC:ASMIY
|
NL |
|
Protalix Biotherapeutics Inc
F:PBDA
|
US |
|
Eli Lilly and Co
NYSE:LLY
|
US |
|
G
|
Gentili Mosconi SpA
MIL:GM
|
IT |
|
Formula One Group
F:LM0D
|
US |
Wall St Price Targets
DRREDDY Price Forecast
Based on 39 analysts
Based on 39 analysts
+4% Upside
from
₹1 200.1
today
Dr Reddy's Laboratories Ltd (500124)’s 12-month stock price forecast through October 2027 has a consensus target of ₹1 244.2, implying 4% upside. The forecast is based on price targets from 39 Wall Street analysts.
DRREDDY Analyst Rating
No ratings yet
No ratings yet
Dr Reddy's Laboratories Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DRREDDY's stock price target?
Price Target
1 244.2
INR
1 244.2
INR
According to Wall Street analysts, the average 1-year price target for DRREDDY is 1 244.2 INR with a low forecast of 1 044.08 INR and a high forecast of 1 817.76 INR.
What is the Revenue forecast for Dr Reddy's Laboratories Ltd?
Projected CAGR
8%
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 5 years is 8%.
What is the Gross Profit forecast for Dr Reddy's Laboratories Ltd?
Projected CAGR
6%
6%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 5 years is 6%.
What is the Operating Income forecast for Dr Reddy's Laboratories Ltd?
Projected CAGR
17%
17%
Over the last 13 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 5 years is 17%.
What is the Pre-Tax Income forecast for Dr Reddy's Laboratories Ltd?
Projected CAGR
12%
12%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 7%. The projected CAGR for the next 3 years is 12%.
What is the Net Income forecast for Dr Reddy's Laboratories Ltd?
Projected CAGR
16%
16%
Over the last 13 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 5 years is 16%.